Preeclampsia-Like Syndrome in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
Amir Naeh, A. Berezowsky, M. Yudin
Oct 1, 2021
Citations
7
Citations
Quality indicators
Journal
Journal of Obstetrics and Gynaecology Canada
Full text
Semantic Scholar
Key Takeaway Key Takeaway: COVID-19 infection in pregnancy may present as preeclampsia-like syndrome, and placental growth factor testing can help differentiate between the two conditions for appropriate management.
Abstract
Background Hypertension, proteinuria, and hepatic dysfunction have been described as manifestations of coronavirus disease 2019 (COVID-19) and are generally accepted as poor prognostic factors. However, these same findings can also occur in pregnant women with preeclampsia, thus creating a diagnostic challenge. Case We report a case of COVID-19 infection in an otherwise healthy pregnant patient with secondary hypertension, proteinuria, and significant hepatic dysfunction. Maternal placental growth factor (PlGF) testing was used to rule out preeclampsia. The patient received supportive care and improved significantly. She went on to have a spontaneous vaginal term delivery of a healthy male baby. Conclusion COVID-19 infection in pregnancy may present as preeclampsia-like syndrome. PlGF testing can be used to differentiate preeclampsia from COVID-19 and facilitate appropriate management.